tiprankstipranks
Mesoblast Limited (MEOBF)
OTHER OTC:MEOBF
US Market
MEOBF
Mesoblast Limited
RESEARCH TOOLSreports

Mesoblast Limited (MEOBF) Stock News & Sentiment

72 Followers
Mesoblast Outlines R&D Outlook and Flags Risks Around Stem Cell Pipeline
Premium
Company Announcements
Mesoblast Outlines R&D Outlook and Flags Risks Around Stem Cell Pipeline
3d ago
Mesoblast Targets Revenue Expansion and Pipeline Upside at Inaugural R&D Day
Premium
Company Announcements
Mesoblast Targets Revenue Expansion and Pipeline Upside at Inaugural R&D Day
3d ago
Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy
Premium
Company Announcements
Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy
4d ago
Mesoblast Seeks ASX Quotation for 1.26 Million New Shares
Premium
Company Announcements
Mesoblast Seeks ASX Quotation for 1.26 Million New Shares
4d ago
Mesoblast Plans New Share Issue to Raise Capital
Premium
Company Announcements
Mesoblast Plans New Share Issue to Raise Capital
4d ago
Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
Premium
Company Announcements
Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
16d ago
Mesoblast CEO Granted Additional Options Following Shareholder Approval
Premium
Company Announcements
Mesoblast CEO Granted Additional Options Following Shareholder Approval
23d ago
More MEOBF News >

MEOBF News on the Web

Mesoblast (MESO) Gets a Buy from Piper Sandler
TipRanks News
Bullish
Rise and Shine: Everything you need to know before the ASX opens
StockHead
Neutral
Jefferies Reaffirms Their Buy Rating on Mesoblast Limited (MEOBF)
TipRanks News
Neutral
Lunch Wrap: ASX wobbles on shaky ceasefire, Bendigo surges as AI cuts jobs
StockHead
Neutral
Health Check: ‘We’ve only just started’, Mesoblast tells investors at inaugural show-and-tell
StockHead
Neutral
Assessing Mesoblast’s Valuation After FDA Clears New Ryoncil Trial In Duchenne Muscular Dystrophy
Simply Wall St
Neutral
Mesoblast receives IND clearance from FDA for Ryoncil trial
TipRanks News
Neutral
Mesoblast Outlines R&D Outlook and Flags Risks Around Stem Cell Pipeline
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
MEOBF
Sector Average
Media Buzz
This Week15 articles
Weekly Average6.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MEOBF’s Media Buzz Sentiment?
15 articles about MEOBF were published this week. In an average week, 6.25 articles are published.
    What is MEOBF’s weekly average amount of articles?
    In an average week, 6.25 articles about MEOBF are published.
      What is MEOBF’s News Sentiment?
      100% of articles about MEOBF were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week